To cite this paper use one of the standards below:
The molecular mechanism by which guarana powder may decrease the cholesterol uptake from intestinal lumen is not completely clear. To clarify this mechanism, this study aimed to investigate the in vitro binding of bile acids by digested guarana (Paullinia cupana) powder aqueous extract (GPAE) compared to cholestyramine. The GPAE was subjected to in vitro digestion simulating the successive oral, gastric, and intestinal digestion phases and the phenolic profile was performed by a newly developed high performance liquid chromatography (HPLC) UV/VIS and detection was set at 210 nm. Lyophilized samples were diluted in phosphate buffer (0.1M; pH 7.0) at 10 and 5mg/mL. Each sample were combined to 6mM sodium taurocholate solution in phosphate buffer (1:10), incubated (37°C/2h) and centrifuged (26.800g; 10min; 22°C) three times and the supernatants were combined. Cholestyramine resin, a drug that binds bile acid and lowers cholesterol, was also evaluated as a positive control at the same conditions. The concentration of bile acids was quantified spectrophotometrically (405nm) in a plate reader using Total Bile Acids Assay kit. The results were given as μmol of bile acid bound per gram of sample and all analyses were performed in triplicate. There was a high bioaccessibility of catechin (181.16%), epicatechin (136.78%) and caffeine (213.51%), since the concentrations of these compounds obtained after in vitro digestion were higher (p < 0.05) when compared to the undigested samples, which can be explained by the release of these compounds from the food matrix after the action of digestive enzymes. The digested GPAE demonstrated a binding capacity to sodium taurocholate of 45.63 (±8.50)% at 1.0mg/mL and 44.30 (±8.88)% at 0.5 mg/mL. Considering cholestyramine as 100% bound, the relative in vitro bile acid binding capacity percentages correspond to 71.78 (±13.36)% and 93.11 (±18.65)% at the same concentrations, respectively. Although we observed a slightly lower binding capacity to sodium taurocholate by GPAE when compared to cholestyramine, these values were not statistically different. This demonstrates that guarana has a binding capacity to bile acids comparable to that of drugs used for this purpose. This study concluded that digested GPAE may inhibit intestinal lipid digestion, helping to excrete more bile acids and delaying lipid absorption, presenting potential application as a cholesterol-reducing agent for hypercholesterolemic patients, probably mainly due to its phenolic compounds content.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper